Health PolicyTowards an improved investment approach for an effective response to HIV/AIDS
Introduction
By 2010, extraordinary amounts of political commitment, social mobilisation, and HIV/AIDS funding had resulted in an unprecedented scale-up of HIV/AIDS prevention, treatment, care, and support, a decline in incidence of new HIV infections in several countries, more than 6·5 million people receiving antiretroviral therapy, and millions of orphans able to receive basic education, health, and social protection.1, 2 Such large-scale investments helped progress towards more tolerant and enabling social environments.3 However, despite these impressive gains, universal access to prevention, treatment, care, and support for HIV/AIDS is not available worldwide,4 and is unlikely to be achieved with the present pace of change and with the present approaches to investment.
Previously set global targets and associated resource needs estimates5, 6 were effective for mobilisation of unprecedented resources and driving of major progress in the HIV/AIDS response, but were based on the prevailing commodity approach that targeted scale-up of discrete interventions rather than overall results, and led in many cases to fragmentation of the response.7, 8
The approach adopted until now has various shortcomings. First, estimates of future coverage of intervention programmes were made on the basis of a large number of ambitious—and often aspirational—targets, which were not met. Second, subsequent revisions shortened the timeframe available to meet targets, making them further out of reach with increasingly unrealistic programmatic and cost assumptions. Third, as the complexities and costs of a public health response to the HIV/AIDS epidemic and the systemic weaknesses that impeded progress became apparent, the commodity approach was not conducive for countries and donors to set priorities as shown by substantial differences in resource allocation for national HIV/AIDS responses between neighbouring countries with equivalent epidemics. Unsystematic prioritisation and investment were allowed to persist9 as interests and stakeholders competed for a proportion of available funding for HIV/AIDS, spreading resources thinly between many objectives.10
New approaches are needed to achieve universal access and the specific targets included in the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2011–15 strategy and the United Nations Secretary General's Report to the General Assembly in June, 2011.4, 11 A change from the commodity approach to a targeted strategic investment programme driven by the latest evidence is needed to produce substantial and lasting effects on the HIV/AIDS epidemic and make the most of investment in the response.
We propose an investment framework to support management of national and international HIV/AIDS responses, encourage transparency in programme objectives and results, and enable decision makers and financiers to galvanise support for effective action. The framework differentiates between basic programme activities that aim to directly reduce HIV transmission, morbidity, and mortality; activities that are necessary to support the effectiveness and efficiency of these programmes (critical enablers); and investments in other sectors that can have a positive effect on HIV outcomes (synergies with development sectors; figure 1). The framework promotes prioritisation of efforts on the basis of a nuanced understanding of country epidemiology and context, and assumes major efficiency gains as delivery of care evolves from facility-based to community-based structures.12
The framework aims to enhance present efforts to make the most of HIV/AIDS responses, including the Global Fund to Fight AIDS, Tuberculosis and Malaria's new approach to fund countries on the basis of national strategy applications13 rather than discrete projects.14 Equally, the framework supports improved planning for resource allocation in the largest bilateral HIV/AIDS programme, the US President's Emergency Plan for AIDS Relief (PEPFAR), which has a new and explicit focus on increased country ownership.15 The framework will encourage countries to make the most of their programmatic responses to the epidemic through careful targeting and selection of the most effective interventions.
In this Health Policy, we present the investment framework and apply it in a costing exercise undertaken to estimate the resources needed to implement a global HIV/AIDS response in the next decade.
Section snippets
Outline
The approach previously taken by UNAIDS estimated total resource needs on the basis of unit costs and coverage targets for all commonly undertaken prevention, treatment, care, and support activities for HIV/AIDS.5, 6 Infections and deaths averted were modelled on the basis of the estimated effect of each of these interventions. The aids 2031 project16 subsequently used much the same model to develop various scenarios for global HIV/AIDS responses; in their most optimistic scenario all component
Resources needed for the new investment framework
Our modelling exercise estimates resource needs and returns on investment for 139 low-income and middle-income countries. The resource needs estimate is the cost of increasing from present rates of coverage in 2011 to achieve universal access by 2015 and maintain it thereafter. For the baseline scenario, we assumed constant coverage at about present funding rates72 and approaches except for the reductions in antiretroviral drug costs which we assumed would decline over time at the same rate in
Investments in HIV/AIDS and returns
Table 2 and figure 3 show the financing needed for the full rollout of this new investment framework for 2011–20. Resource needs increase from present rates of about US$16 billion to peak at $22 billion in 2015 when universal coverage will be achieved. Resource needs will then decline after 2015 for three main reasons: first, coverage will have reached target rates for the interventions included in the new framework and will be kept stable at these rates; second, efficiency gains will continue
Development synergies
Our estimate of financing needs to achieve strong synergies with development sectors was based on costs of gender-based violence programmes, a number of health-sector elements, youth in schools programmes, workplace education, and provision for children orphaned by HIV/AIDS (see webappendix pp 24–25). The total cost was $3·6 billion for 2011, increasing to about $5·4 billion by 2020 (table 2). While this framework does not intend to be prescriptive about spending to support sectoral synergies,
Discussion
The United Nations high-level meeting on HIV/AIDS in June, 2011, provides an unrivalled opportunity to take stock of the striking progress made in the response to HIV/AIDS since the United Nations General Assembly Special Session on HIV/AIDS 10 years ago.78 The meeting will allow gaps in the response to be identified and generate high-level political commitment for a substantial shift in the HIV/AIDS response to ensure programme improvement. We propose a new investment framework to guide
References (88)
- et al.
The history and challenge of HIV prevention
Lancet
(2008) - et al.
HIV and risk environment for injecting drug users: the past, present, and future
Lancet
(2010) - et al.
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Lancet
(2010) - et al.
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial
Lancet
(2007) - et al.
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
Lancet
(2007) - et al.
Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review
Lancet Infect Dis
(2010) - et al.
HIV-positive mothers in Viet Nam: using their status to build support groups and access essential services
Reprod Health Matters
(2008) - et al.
The Global Fund's leadership on harm reduction: 2002–2009
Int J Drug Policy
(2010) - et al.
Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial
Lancet
(2006) - et al.
Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea
Lancet
(2008)
AIDS 2011: progress, ownership and shared accountability
Children and AIDS: fifth stocktaking report, 2010
Report on the global AIDS epidemic
Report of the Secretary-General: uniting for universal access: towards zero new HIV infections, zero discrimination and zero AIDS-related deaths
AIDS. Resource needs for HIV/AIDS
Science
What countries need. Investments needed for 2010 targets
An assessment of interactions between global health initiatives and country health systems
Lancet
Report on the global AIDS epidemic 2008
Draft working paper: assessing costing and prioritization in national AIDS strategic plans. Results for development institute/AIDS 2031
UNAIDS 2011–2015 strategy: getting to zero
The Global Fund 2010. Innovation and impact
Health systems funding platform pilot. Final decision points for the 22nd board meeting
National strategy aplications first learning wave. Final decision points for the 18th board meeting
PEPFAR: making smart investments to increase impact and efficiency and save more lives
Costs and choices: financing the long-term fight against AIDS
Declines in risk behaviour and sexually transmitted infection prevalence following a community-led HIV preventive intervention among female sex workers in Mysore, India
AIDS
People, passion & politics: looking back and moving forward in the governance of the AIDS response
Glob Health Gov
Integration of targeted health interventions into health systems: a conceptual framework for analysis
Health Policy Plan
Evidence-based public health: moving beyond randomized trials
Am J Public Health
Weighing the gold in the gold standard: challenges in HIV prevention research
AIDS
How can we calculate the “E” in “CEA”?
AIDS
Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV infection
Clin Infect Dis
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 trial
PLoS Med
Redefining AIDS in Asia: crafting an effective response. Report of the Commission on AIDS in Asia
Kenya HIV prevention response and modes of transmission analysis
New HIV infections by mode of transmission in West Africa: a multi-country analysis
Harm reduction: evidence, impacts and challenges
WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia
AIDS
Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti
Sex Transm Infect
A review of STD/HIV preventive interventions for adolescents: sustaining effects using an ecological approach
J Pediatr Psychol
HIV decline associated with behavior change in eastern Zimbabwe
Science
A surprising prevention success: why did the HIV epidemic decline in Zimbabwe?
PLoS Med
Cited by (373)
Contraception Initiation in the Emergency Department: Adolescent Perspectives
2024, Journal of Adolescent HealthAdapting Economic Evaluation Methods to Shifting Global Health Priorities: Assessing the Value of Health System Inputs
2024, Value in Health Regional IssuesHealthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties
2023, Journal of HepatologyThe impact of COVID-19 on essential health service provision for endemic infectious diseases in the South-East Asia region: A systematic review
2022, The Lancet Regional Health - Southeast AsiaPharmaceutical regulatory requirements of nonregulated markets
2022, Regulatory Affairs in the Pharmaceutical IndustryBayesian validation framework for dynamic epidemic models
2021, Epidemics
- ‡
Members listed at end of paper